Joanne Mortimer, MD
City of Hope Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Joanne Mortimer, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:28 UTC. Open this list on ClinicalTrials.gov
- N/ANCT04661982 · Long Term Follow-Up in Patients With Stage 0-IIIC Breast CancerCity of Hope Medical Center · active not recruiting · Breast Cancer · principal investigator
- Ph2NCT04305834 · Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.City of Hope Medical Center · recruiting · Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Carcinoma, Metastatic Breast Carcinoma · principal investigator
- Ph1NCT04020575 · Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)Minerva Biotechnologies Corporation · recruiting · Metastatic Breast Cancer · principal investigator
- Ph2NCT01730833 · Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast CancerCity of Hope Medical Center · completed · HER2-positive Breast Cancer, Recurrent Breast Cancer, Stage IIA Breast Cancer · principal investigator
- Ph2NCT01525966 · Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast CancerCity of Hope Medical Center · active not recruiting · Inflammatory Breast Cancer, Stage IIA Breast Cancer, Stage IIIA Breast Cancer · principal investigator
- Ph2NCT00295893 · Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast CancerCity of Hope Medical Center · active not recruiting · Breast Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:28 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Leadership, Planning and EvaluationP30CA033572 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI JOHN D. CARPTEN · fiscal years 2005 to 2026Named on NCT04305834, NCT00295893
- Role of miR-105 in breast cancer metastasisR01CA166020 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Shizhen Emily Wang · fiscal years 2012 to 2016Named on NCT01730833
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in breast cancer.